Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
for Immune Thrombocytopenia
9 locations incl. Clovis
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT07007962·Phase 3·Recruiting